Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatment

被引：2
|
作者：
Teuber, G
Pascu, M
Lafrenz, M
Weidenbach, H
Schoelmrich, J
Wietzke-Braun, P
Arnold, R
Pausch, J
Lock, G
Zeuzem, S
机构：
[1] UNIKlin, Med Klin 2, D-60590 Frankfurt, Germany
[2] Klin & Poliklin Innere Med, D-18055 Rostock, Germany
[3] Univ Klinikum Charite, D-13352 Berlin, Germany
[4] Med UNI Klin, D-89081 Ulm, Germany
[5] UniKlin, Gastroenterol Abt, Gottingen, Germany
[6] UNIKlin, Klin & Poliklin Innere Med, D-93042 Regensburg, Germany
[7] UNIKlin, Zentrum Innere Med, D-35033 Marburg, Germany
[8] Staedt Klinikum, Med Klin 1, D-34125 Kassel, Germany
[9] UNIKlin, Med Klin 2, D-60590 Frankfurt, Germany
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80472-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
472
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [11] A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin
    Ciancio, A.
    Picciotto, A.
    Giordanino, C.
    Smedile, A.
    Tabone, M.
    Manca, A.
    Marenco, G.
    Garbagnoli, P.
    Andreoni, M.
    Cariti, G.
    Calleri, G.
    Sartori, M.
    Cusumano, S.
    Grasso, A.
    Rizzi, R.
    Gallo, M.
    Basso, M.
    Anselmo, M.
    Percario, G.
    Ciccone, G.
    Rizzetto, M.
    Saracco, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (07) : 1079 - 1086
  • [12] Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin
    Teuber, G
    Kallinowski, B
    Niederau, C
    Klinker, H
    Galle, PR
    Zankel, M
    Zeuzem, S
    JOURNAL OF HEPATOLOGY, 2003, 38 : 176 - 176
  • [13] Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
    Ferenci, P
    Stauber, R
    Hackl, F
    Schuetze, K
    Bauer, B
    Datz, C
    GASTROENTEROLOGY, 2000, 118 (04) : A1437 - A1437
  • [14] A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naive patients with chronic hepatitis C
    Tassopoulos, NC
    Ketikoglou, I
    Tsantoulas, D
    Raptopoulou, M
    Hatzis, G
    Vafiadis, I
    Sidiropoulos, L
    Kanatakis, S
    Anagnostopoulos, G
    Sypsa, V
    Hatzakis, A
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (05) : 383 - 389
  • [15] Ribavirin plus human leucocyte interferon alpha for the treatment of interferon resistant chronic hepatitis C: A controlled trial
    Toccaceli, F
    Grimaldi, M
    Rosati, S
    Palazzini, E
    Laghi, V
    HEPATOLOGY RESEARCH, 1997, 8 (02) : 106 - 112
  • [16] Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin
    Oliveira, Isabela S.
    Carvalho, Lucas P.
    Schinoni, Maria Isabel
    Parana, Raymundo
    Atta, Ajax M.
    Sousa Atta, Maria Luiza B.
    MICROBIAL PATHOGENESIS, 2016, 91 : 155 - 160
  • [17] Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C
    Teuber, G
    Pascu, M
    Berg, T
    Lafrenz, M
    Pausch, J
    Kullmann, F
    Ramadori, G
    Arnold, R
    Weidenbach, H
    Musch, E
    Junge, U
    Wiedmann, KH
    Herrmann, E
    Zankel, M
    Zeuzem, S
    JOURNAL OF HEPATOLOGY, 2003, 39 (04) : 606 - 613
  • [18] Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaiVE Chronic Hepatitis C Genotype 6
    Lam, Khoa D.
    Trinh, Huy N.
    Do, Son T.
    Nguyen, Thuan T.
    Garcia, Ruel T.
    Nguyen, Tuan
    Phan, Quang Q.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Nguyen, Long H.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2010, 138 (05) : S783 - S783
  • [19] Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Biselli, M
    Di Giammarino, L
    Grazi, GL
    Jovine, E
    D'Errico, A
    Galli, S
    Mazziotti, A
    Cavallari, A
    Bernardi, M
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (08) : 693 - 697
  • [20] High response rates to interferon induction plus ribavirin and amantadine in the treatment of interferon nonresponder chronic hepatitis C patients: A randomized controlled pilot study
    Adinolfi, LE
    Tonziello, A
    Utili, R
    Andreana, A
    Marracino, M
    Sarnataro, G
    Giordano, M
    Ruggiero, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 107 - 107
12345